Intellectual property

The field of human-derived cell and protein products presents substantial barriers to entry, requiring deep expertise across cell biology, bioengineering, manufacturing, regulatory affairs, and their application in aesthetics.

To further strengthen the platform, CELCORE seeks to protect its technology with patents and has obtained a cell technology patent covering Europe, Americas and key Asian and Middle Eastern countries.

The patent (EP3013379B1, US10751276B2) covers the product composition of mesenchymal stem cells and adipose tissue, manufacturing of this composition, and its use as a cosmetic filler.

Furthermore, other patents are pending.